These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2047050)

  • 21. Carbohydrate studies in women using a norethindrone triphasic oral contraceptive for eighteen months.
    Spellacy WN; Ellingson AB; Tsibris JC
    Adv Contracept; 1989 Jun; 5(2):85-90. PubMed ID: 2688381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
    Gossain VV; Sherma NK; Michelakis AM; Rovner DR
    Am J Obstet Gynecol; 1983 Nov; 147(6):618-23. PubMed ID: 6356926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
    Petersen KR; Skouby SO; Dreisler A; Kühl C
    Ugeskr Laeger; 1987 Jun; 149(24):1614-6. PubMed ID: 3111056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 25. [Insulin and proinsulin secretion under contraceptive steroid administration (author's transl)].
    Hausmann L; Goebel KM; Klähn D; Kaffarnik H
    Klin Wochenschr; 1975 Sep; 53(18):853-60. PubMed ID: 1165627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR; Gaspard UJ
    Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of oral contraceptive agents on copper and zinc balance in young women.
    Crews MG; Taper LJ; Ritchey SJ
    Am J Clin Nutr; 1980 Sep; 33(9):1940-5. PubMed ID: 7416062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives and blood coagulation.
    Bonnar J; Sabra AM
    J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
    Skouby SO; Andersen O; Saurbrey N; Kühl C
    J Clin Endocrinol Metab; 1987 Mar; 64(3):519-23. PubMed ID: 3102539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized prospective studies on metabolic effects of oral contraceptives.
    Briggs MH; Briggs M
    Acta Obstet Gynecol Scand Suppl; 1982; 105():25-32. PubMed ID: 6805241
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hormonal contraceptives in female rowers].
    Lisý Z
    Cas Lek Cesk; 1984 Aug; 123(35):1086-90. PubMed ID: 6498900
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of an oral contraceptive on plasma growth hormone and glucose tolerance in two strains of rats.
    Arnold TS; Thye FW
    Am J Clin Nutr; 1977 Mar; 30(3):381-7. PubMed ID: 842489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives.
    Beck P; Venable RL; Hoff DL
    J Clin Endocrinol Metab; 1975 Jul; 41(1):44-53. PubMed ID: 50326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The action of Sequostat in comparison to Sequence Ovosiston on selected metabolic parameters].
    Etzrodt R; Klinger G; Carol W
    Zentralbl Gynakol; 1990; 112(8):489-96. PubMed ID: 1694614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral contraceptive agents on nutrients: II. Vitamins.
    Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
    Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indicators of arterial blood pressure during hormonal contraception].
    Trutko NS; Dubnitskaia LV; Kuramshina AKh
    Akush Ginekol (Mosk); 1985 Aug; (9):56-7. PubMed ID: 2416229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulatory influence of oral contraceptives on mammary growth pattern of normal and ovariectomised mice.
    Ecavade A; Rao AR
    Contraception; 1994 Aug; 50(2):175-83. PubMed ID: 7956216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year carbohydrate metabolism studies in women using a norethindrone or levonorgestrel triphasic oral contraceptive.
    Spellacy WN; Ellingson AB; Tsibris JC
    Adv Contracept; 1990 Sep; 6(3):185-91. PubMed ID: 2123370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical and biochemical effects of two combination oral contraceptive agents.
    Sapire KE; Berger GM; Maritz JS
    S Afr Med J; 1991 Apr; 79(7):376-9. PubMed ID: 1826569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
    Adeniji AA; Essah PA; Nestler JE; Cheang KI
    J Womens Health (Larchmt); 2016 Jun; 25(6):638-45. PubMed ID: 26871978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.